Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

RedHill Biopharma (RDHL) Inventory Average (2017 - 2025)

RedHill Biopharma has reported Inventory Average over the past 9 years, most recently at $3.4 million for Q2 2025.

  • Quarterly Inventory Average fell 16.76% to $3.4 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Jun 2025, down 16.76% year-over-year, with the annual reading at $4.0 million for FY2024, 47.79% down from the prior year.
  • Inventory Average was $3.4 million for Q2 2025 at RedHill Biopharma, down from $3.7 million in the prior quarter.
  • Over five years, Inventory Average peaked at $13.0 million in Q2 2022 and troughed at $3.4 million in Q2 2025.
  • The 5-year median for Inventory Average is $8.7 million (2021), against an average of $8.3 million.
  • Year-over-year, Inventory Average skyrocketed 239.77% in 2021 and then plummeted 60.46% in 2023.
  • A 5-year view of Inventory Average shows it stood at $10.4 million in 2021, then rose by 13.35% to $11.8 million in 2022, then plummeted by 60.46% to $4.7 million in 2023, then decreased by 20.08% to $3.7 million in 2024, then decreased by 8.52% to $3.4 million in 2025.
  • Per Business Quant, the three most recent readings for RDHL's Inventory Average are $3.4 million (Q2 2025), $3.7 million (Q4 2024), and $4.1 million (Q2 2024).